Page 36 - MEMOCiberesp014-ENG

Phase I: Analysis of 11 technologies, prioritization by transfer potential and selection of 5 technologies with greatest potential for an in-depth evaluation .
Phase II: Comprehensive analysis of the 5 prioritized technologies, evaluating the main key factors of the 5 projects with greater market transfer potential in order to select the project having the greatest transfer potential .
Phase III: Preparation of a development plan so that the selected technology successfully reaches significant milestones which allow licensing it to an industrial partner .
Each technology will be evaluated from the technological offer viewpoint (evaluating the degree of develo- pment and technological competitiveness) and from the business demand viewpoint (evaluating the market needs, market size and value generating potential) .
This process is being carried out with advice from a consultant specializing in strategic consultancy and project assessment .
Technological offer and congresses
Informative material in the form of leaflets, posters, patent and project flyers, etc ., has been maintained with updated information of our technological offer and with all the service units grouped into a single infrastructure .
CIBER-BBN has participated in the following forums in which our technological offer was disseminated, establishing relations that may lead to future collaborations:
• European Infrastructure Conference, ESFRI, ISCIII, Madrid, January 2014 . • OFTARED-Cluster4eye Forum . ISCIII, Madrid, January 2014 . • ARTEMIS Pre-Brokerage Event 2014, Brussels, February 2014 . • H2020NMP Conference, Madrid, February 2014 .
• 7th Annual Conference of Biomedical Research Technological Platforms: Innovative Drugs, Nanomedicine, Health Technology and Biotechnology Markets, Barcelona, March 2014 .
• Market Access Topic Group Meeting, ASEBIO, Madrid, April 2014 . • Annual CEBR Meeting, Coimbra, April 2014 . • Internal CTLS Congress, Paris, June 2014 . • Life Sciences Introduction Conference: Investment opportunities, SF Biotech, Barcelona, June 2014 . • Life Sciences Workshop . Madrid Network–US Davis Research . CSIC, Madrid, June 2014 .
• BIO International Convention, San Diego, USA, June 2014 . • Advanced Therapy Legislation Meeting, AEMPS, Madrid, July 2014 . • European Biomedical Investor Day, Biocat, Barcelona, September 2014 . • BIOSPAIN, Santiago de Compostela, September 2014 . • Advanced Therapy Conference, ISCIII, Madrid, October 2014 . • Flag-ERA Graphene Networking Event, Barcelona, October 2014 . • ETP Nanomedicine Annual Event and General Assembly 2014, San Sebastián, October 2014 . • Bio-Europe, Frankfurt, Germany, November 2014 . • Brockerage Event Nanofutures, Brussels, November 2014 . • CAT-Hearing with Interested Parties, EMA, London, UK, December 2014 .
36
CIBER-BBN » Annual report 2014